Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Int Forum Allergy Rhinol. 2017 Jan 24;7(4):359–364. doi: 10.1002/alr.21914

Figure 2.

Figure 2

Levofloxacin treatment leads to increased Caspase-3 activity which is reduced by pretreatment with sulforaphane. Caspase-3 activity was detected by colorimetric assay after SNECs were treated for 48-hours levofloxacin (0,20,40, or 80μg/mL) alone (black squares), or pretreated for 24 hours with 10μM sulforaphane (open circles). Colorimetric output of the assay is shown as arbitrary units (A.U.) +/− the standard error of the mean (s.e.m). * indicates p< 0.05 +/− sulforaphane treatment.